EFSA Journal · 2017 · 87 citations · 33 references
PharmacyEnvironmental SciencesToxicologyAnalytical ToxicologyPesticide ToxicologyRegulatory ToxicologyHazardous Substances RegulationPesticide RegulationPesticide Residue AnalysisPesticide Residue RegulationPesticide ResiduesPesticide Risk AssessmentCodex Pesticide Residue StandardsCodex Residue StandardsConsumer's RiskMaximum Residue Limit AssessmentPesticide Safety AssessmentResidue Detection LimitsResidue SafetySource Substances
In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to provide support for the preparation of the EU position for 49th session of the Codex Committee on Pesticide Residues (CCPR). In 2016, JMPR evaluated 12 active substances regarding the setting of toxicological reference values to be used in consumer risk assessment (acibenzolar-S-methyl, fenpropimorph, fluazifop-P-butyl, fluensulfone, imazethapyr, isofetamid, oxathiapiprolin, penconazole, pendimethalin, pinoxaden, spiromesifen and teflubenzuron) and 24 active substance regarding the setting of Maximum Residue Limits (MRLs) (acibenzolar-S-methyl, benzovindiflupyr, bixafen, buprofezin, chlorantraniliprole, deltamethrin, dimethomorph, fipronil, fluazifop-P-butyl, fluensulfone, flupyradifurone, imazethapyr, isofetamid, methoprene, metrafenone, oxathiapiprolin, penconazole, pendimethalin, pinoxaden, saflufenacil, spiromesifen, sulfoxaflor, teflubenzuron and tolfenpyrad); EFSA prepared comments on the Codex MRL proposals and the proposed toxicological reference values. In addition, EFSA provided the views on follow-up assessments of JMPR on pesticides where specific concerns were raised in the previous CCPR meetings. The current report should serve as the basis for deriving the EU position for the CCPR meeting are summarised in this report.
33
Update: use of the benchmark dose approach in risk assessment
Diane Benford, Michael Jeger, Katrine Helle Knutsen et al. · EFSA Journal · 2017 · 508 citations · Full text
Guidance on the use of the benchmark dose approach in risk assessment
Simon J. More, Vasileios Bampidis, Diane Benford et al. · EFSA Journal · 2022 · 210 citations · Full text